Joseph V. Rodricks, Ph.D., D.A.B.T. [Chair] is a founding Principal of ENVIRON International, a consulting firm, and Visiting Professor at the Johns Hopkins University Bloomberg School of Public Health. Dr. Rodricks has consulted for hundreds of manufacturers, for government agencies, and the World Health Organization. He has more than 200 publications on toxicology and risk analysis, and has lectured nationally and internationally on these topics. Dr. Rodricks was formerly Deputy Associate Commissioner, Health Affairs, and Toxicologist, US Food & Drug Administration (1965-1980). During his time at the agency he was heavily involved in the formation of the National Toxicology Program, and in a host of other interagency efforts, including the development of the first federal guidelines for the conduct of risk assessment. His experience extends from pharmaceuticals, medical devices and foods, to occupational chemicals and environmental contaminants. He currently serves on the National Academy of Sciences-National Research Council Board on Environmental Studies and Toxicology, and has served on 25 Committees of the NRC and the IOM, including the Committee that produced the seminal work Risk Assessment in the Federal Government (1983). Dr. Rodricks has received distinguished service awards from the Society for Risk Analysis and from the Food and Drug Law Institute. In 2003, he was awarded a lifetime appointment as a National Associate of the National Academy of Sciences. He holds a PhD in biochemistry and is a Diplomate, American Board of Toxicology.

 R. Kenneth (Ken) Marcus, Ph.D. is Professor of Analytical Chemistry and Director of the Center for the Chemical Characterization of Botanical Products at Clemson University in Clemson, South Carolina. Professor Marcus’ research program over the last 20 years has focused on the development of novel instrumentation to solve higher-order analytical chemistry problems. That work has resulted in ~10 US and international patents and numerous journal publications. His research interests include element and species-specific detectors for applications in biological and environmental analyses, with particular emphasis on metal speciation in botanical (nutraceutical) materials. Dr. Marcus was previously a member of the National Research Council Panel on Chemical Science and Technology. He serves on the editorial advisory board of the journals Analytical and Bioanalytical Chemistry, the Journal of Analytical Atomic Spectroscopy, and Spectrochimica Acta, Part B. Dr. Marcus earned a Ph.D. in analytical chemistry from the University of Virginia. In 2001, he was the recipient of the South Carolina Governor’s Award for Excellence in Science Research.

 Monica Nordberg, Ph.D. is Professor of Hygiene/Environmental Medicine at the Karolinska Institutet’s Institute of Environmental Medicine in Stockholm, Sweden. She has published extensively on issues concerning biochemical mechanisms and health effects related to exposure to metals, primarily cadmium, lead, and mercury, and their interaction with selenium. Dr. Nordberg has served on several international panels, including the World Health Organization (WHO) Task Group on Elemental Speciation in Human Health Risk Assessment. She is currently Chair of the International Commission on Occupational Health (ICOH) Scientific Committee on the Toxicology of Metals, Council Member of the International Society for Trace Elements in Humans (ISTERH), and a titular member of the International Union of Pure and Applied Chemistry (IUPAC) Division of Chemistry and Health. Dr. Nordberg is also one of the editors of the Handbook on the Toxicology of Metals, Third Edition. She earned her PhD from the Karolinska Institutet.

 Douglas M. Templeton, Ph.D., M.D. is Professor of Laboratory Medicine and Pathobiology at the University of Toronto, Toronto, Canada. His research interests include trace element biology and analytical toxicology, and he has published over 160 peer-reviewed papers and review articles and co-authored two monographs on occupational health for the World Health Organization. Dr. Templeton has worked extensively in the International Union of Pure and Applied Chemistry (IUPAC), as leader of several working parties, past Secretary to the Commission on Toxicology, and now President of their Division of Chemistry and Human Health. He is Past Chair of the Pharmacology and Toxicology Panel for the Canadian Institutes of Health Research (CIHR). Dr. Templeton earned his PhD in chemistry from Carleton University and MD from the University of Western Ontario.

Michael Wierer, Ph.D. is Deputy Head of the European Pharmacopoeia Department, European Directorate for the Quality of Medicines & HealthCare (EDQM), of the Council of Europe in Strasbourg, France. He began his professional career in the Central Medical Institute of the German Medical Corps in Munich and continued on in the Armed Forces Medical Intelligency Center (Sanitätsamt der Bundeswehr), exercising responsibility for quality and stability testing of drug products used by the military. In 1997, he was appointed head of the Official Medicines Control Laboratory (OMCL) of federal state of North Rhine-Westphalia. Dr. Wierer also served as a member of the German Pharmacopoeia Commission and coordinator of all German OMCLs. He was involved in a joint international initiative of government laboratories (US [FDA], Australia, Canada, Germany, the Netherlands, and the United Kingdom) to combat counterfeiting of active pharmaceutical ingredients and herbal drugs containing toxic compounds in worldwide trade. The achievements of this group were recognized in June 2000 with a US National Partnership for Reinventing Government (Hammer) Award. In 2001, Dr. Wierer joined EDQM, where he assumed responsibility for several programs of the European OMCL network and as scientific administrator of several group of experts to the European Pharmacopoeia. He was appointed to his current position in 2006 and is in this capacity involved in the international harmonization of pharmacopoeial text between the European, the US and the Japanese pharmacopeias. Dr. Wierer studied pharmaceutical sciences and food chemistry, and earned his PhD in pharmaceutical biology from the Ludwig-Maximilians-Universität München.